Literature DB >> 22703702

[Emergence of resistance to third generation cephalosporins by Enterobacteriaceae causing community-onset urinary tract infections in hospitals in Colombia].

Aura Lucía Leal1, Jorge Alberto Cortés, Gerson Arias, María Victoria Ovalle, Sandra Yamile Saavedra, Giancarlo Buitrago, Javier Antonio Escobar, Betsy Esperanza Castro.   

Abstract

INTRODUCTION: Urinary tract infection (UTI) is a common disease in the community, and a matter of concern due to the increasing resistance of microorganisms to first line antibiotics and the emergence of multiresistant strains producing extended spectrum beta lactamases (ESBL) in the community.
METHODS: An analytical case-control study was conducted over twelve months in 9 hospitals in Colombia. We collected isolates of E. coli, Klebsiella spp. and Proteus spp. from patients with community-onset UTI. The presence of ESBL, AmpC and KPC beta-lactamases were characterized by microbiological and molecular methods. The aim of this study was to determine factors related to the presence of these mechanisms of the resistance to third generation cephalosporins.
RESULTS: A total of 325 isolates (287 E. coli, 29 Klebsiella spp. and 9 Proteus spp.) were included. The most frequent comorbidities among the patients were hypertension (n=82; 25.2%) and diabetes mellitus (n=68; 20.9%). Previous use of antimicrobials was found in 23% of patients, and 29% had a previous UTI. Resistance to third and fourth generation cephalosporins varied between 3.4% and 6.3% in E. coli and between 6.9% and 17.8% in K. pneumoniae. Seven (2.4%) CTX-M-15 ESBL-producing E. coli isolates were detected; four of them belonged to ST 131 clone. In K. pneumoniae we detected three KPC-3 carbapenemases (10.3%).
CONCLUSIONS: This study confirms the emergence of resistance to third generation cephalosporins enterobacteriaceae as a cause of community-onset UTI. We emphasize the presence of ST 131 clone and KPC carbapenemases circulating in Colombia outside the hospital environment.
Copyright © 2011 Elsevier España, S.L. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22703702     DOI: 10.1016/j.eimc.2012.04.007

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin        ISSN: 0213-005X            Impact factor:   1.731


  6 in total

1.  Impact of urinary catheter on resistance patterns and clinical outcomes on complicated urinary tract infection.

Authors:  Carlos Ernesto Lombo Moreno; Oscar Mauricio Muñoz Velandia; Cindy Alejandra Bonilla Sánchez; Juan Sebastián Montealegre Diaz; Javier Ricardo Garzón Herazo
Journal:  Int Urogynecol J       Date:  2022-08-22       Impact factor: 1.932

2.  [Prevalence and risk factors for extended-spectrum β-lactamase-producing Escherichia coli causing community-onset urinary tract infections in Colombia].

Authors:  Victor M Blanco; Juan J Maya; Adriana Correa; Marcela Perenguez; Juan S Muñoz; Gabriel Motoa; Christian J Pallares; Fernando Rosso; Lorena Matta; Yamile Celis; Martha Garzon; María V Villegas
Journal:  Enferm Infecc Microbiol Clin       Date:  2016-01-13       Impact factor: 1.731

3.  High Heterogeneity of Escherichia coli Sequence Types Harbouring ESBL/AmpC Genes on IncI1 Plasmids in the Colombian Poultry Chain.

Authors:  Luis Ricardo Castellanos; Pilar Donado-Godoy; Maribel León; Viviana Clavijo; Alejandra Arevalo; Johan F Bernal; Arjen J Timmerman; Dik J Mevius; Jaap A Wagenaar; Joost Hordijk
Journal:  PLoS One       Date:  2017-01-26       Impact factor: 3.240

Review 4.  Resistant gram-negative infections in the outpatient setting in Latin America.

Authors:  M J C Salles; J Zurita; C Mejía; M V Villegas
Journal:  Epidemiol Infect       Date:  2013-08-07       Impact factor: 2.451

5.  Development and validation of a scoring system for predicting cancer patients at risk of extended-spectrum b-lactamase-producing Enterobacteriaceae infections.

Authors:  Alvaro J Martínez-Valencia; Brian J Gómez Martínez; Anita M Montañez Ayala; Katherin García; Ricardo Sánchez Pedraza; Leydy P Jiménez Cetina; Julio C Gómez Rincón; Sonia I Cuervo Maldonado
Journal:  BMC Infect Dis       Date:  2020-07-31       Impact factor: 3.090

6.  Detection of CMY-type beta-lactamases in Escherichia coli isolates from paediatric patients in a tertiary care hospital in Mexico.

Authors:  Jocelin Merida-Vieyra; Agustín De Colsa-Ranero; Yair Calderón-Castañeda; Alejandra Aquino-Andrade
Journal:  Antimicrob Resist Infect Control       Date:  2020-10-29       Impact factor: 4.887

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.